 |
 |
| |
|
 |
Dr Feigal is a partner in NDA Partners. He held senior positions in all three
FDA medical product Centers including service as former Center Director, CDRH,
former Deputy Center Director, CBER and former Director of the Office of Drug
Evaluation IV (Anti-infective-Antiviral Drug Products), CDER. He has a detailed
understanding of the relationship between scientific evidence and regulatory
strategy in product development. Before joining FDA, Dr. Feigal was an Associate
Professor at the University of California, San Diego, in the Department of Medicine
and is trained as a Clinical Epidemiologist. In September 2006 Dr. Feigal joined Elan Pharmaceuticals as Vice President, Head of Global Regulatory and Global Safety Surveillance.
|
|
|
|
|
|
